Top 50 Ai Diagnostics in LATAM

The startup develops laboratory-based diagnostic tests utilizing artificial intelligence, algorithms, and epigenomic profiling to detect all major subtypes of breast cancer from stage 1 to 4. With a sensitivity and specificity of 98.5%, their tests enable early and accurate cancer diagnosis, improving treatment outcomes for patients.

Neomed offers a digital platform focused on cardiovascular health, providing solutions for disease prevention, management, and remote diagnostics. Their integrated tools support the full patient journey, from early detection to emergency care, for clinics, hospitals, and healthcare providers. Neomed aims to improve cardiac health outcomes through technology-driven solutions.

Onc.ai develops AI models leveraging oncology real-world data, including imaging, EMR, and genomics, to enhance precision oncology. The company's deep learning imaging AI aims to bring clarity to cancer treatment decision-making for medical oncologists. Initial products focus on predicting clinical outcomes in metastatic lung cancer to support pharmaceutical clinical development.

PROSPERiA is a healthtech company focused on democratizing healthcare access through Artificial Intelligence solutions. The core platform automatically analyzes retina images to prevent blindness. This analysis provides personalized recommendations for both patients and medical professionals.

Exo develops handheld ultrasound devices integrated with artificial intelligence for imaging and therapeutic applications in medical settings. These devices enhance diagnostic accuracy and treatment efficiency, addressing the need for portable and user-friendly imaging solutions in healthcare.

FREQX utilizes advanced signal analysis and mechanism-driven intelligent diagnostics to provide precise health assessments for industrial machinery. This technology enables early detection of potential failures, reducing unplanned downtime and maintenance costs for clients.

Onward Assist is a predictive analytics platform that utilizes AI-driven image analysis to enhance cancer diagnosis by identifying biomarkers and reducing reporting time by 30-40%. The platform addresses the lack of effective cancer scoring tools tailored for diverse populations, enabling pathologists to make more accurate treatment decisions efficiently.

Asistx is a real-time telemedicine platform that integrates remote patient monitoring (RPM) and artificial intelligence to enhance patient diagnosis and ongoing health management. The platform addresses the inefficiencies in traditional healthcare by enabling continuous monitoring and proactive intervention for chronic and acute conditions, significantly reducing response times and improving patient outcomes.

OmnigenicsAI is an AI-driven genomics company that provides secure, precise biological data to empower individuals in managing their health through personalized genomic insights. Their services include specialized genetic testing and telemedicine consultations, enabling proactive health management and informed healthcare decisions across all life stages.

The startup has developed a non-invasive health assessment device that utilizes eye-tracking and machine learning algorithms to predict the onset of Alzheimer's disease by quantifying cognitive performance and monitoring subtle changes over time. This technology enables health professionals to accurately assess executive, attentional, and memory functions, facilitating early diagnosis of neurocognitive disorders.

Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.

Sofya is a clinical reasoning platform that utilizes explainable AI to automate routine tasks and support complex clinical decision-making, integrating seamlessly with electronic health records. By enhancing efficiency and personalization in patient care, Sofya addresses the overwhelming administrative burden on healthcare professionals, reducing the time spent on digital paperwork and minimizing medical errors.

Embryoxite develops an AI-powered platform that analyzes embryo metabolomic data, genetic profiles, and morphokinetic imaging to assess implantation potential in pre-implantation embryos. This technology addresses the high failure rate of embryo implantation in IVF procedures by providing objective, data-driven insights that enhance selection accuracy and improve pregnancy outcomes.

The startup develops an artificial intelligence-based respiratory health monitoring system that analyzes individual and population-level respiratory data to track disease progression and treatment outcomes. This technology enables healthcare providers to implement timely interventions for patients with respiratory illnesses, improving overall care quality.

The startup develops a generative artificial intelligence infrastructure that utilizes agent-based model-agnostic technology for evaluating and monitoring healthcare applications. Its software enables healthcare institutions to enhance operational efficiency and improve clinical outcomes by providing proprietary evaluation techniques and end-to-end lifecycle management.

Eden develops a cloud-based Picture Archiving and Communication System (PACS) that centralizes medical imaging operations, enabling rapid DICOM image loading and automated patient result delivery. This technology reduces operational redundancies and enhances diagnostic efficiency for over 1,800 healthcare institutions across Latin America.

Eyecare Health develops advanced diagnostic tools and software solutions for ophthalmology, focusing on improving the accuracy of eye disease detection and treatment planning. The company addresses the challenges of timely and precise diagnosis in eye care, enhancing patient outcomes through data-driven insights.

The startup develops an AI-driven health tech software that enhances patient-clinic interactions through personalized and secure communication. This solution improves patient engagement and adherence to treatment, leading to better health outcomes in healthcare settings.

CLARA Analytics offers CLARAty.ai, an AI-driven Claims Intelligence Platform that utilizes Document Intelligence to analyze claims documents and medical records, providing actionable insights for risk professionals and adjusters. The platform addresses high loss costs and claim expenses by optimizing claims management processes and reducing the time required for medical cost projections and fraud detection.

The startup is developing a Clinical Digital Twin Platform that creates virtual replicas of patients using real-time health data and advanced modeling techniques. This platform enables healthcare providers to personalize treatment plans and improve patient outcomes by simulating various clinical scenarios.

The startup provides digital laboratory services that connect healthcare professionals with patients for at-home diagnostics and vaccination administration. This approach enhances access to essential healthcare services, addressing the challenge of limited patient mobility and the need for convenient medical care.

Univa is developing digital tools that utilize data analytics and machine learning to enhance the management, monitoring, and treatment of eating disorders, addressing the critical shortage of accessible and effective care. By collaborating with healthcare teams, Univa aims to improve patient outcomes and reduce the high morbidity and mortality rates associated with these conditions.

Munai provides an AI-driven clinical intelligence platform that integrates with electronic health records to analyze patient data in real-time. The system automates protocols, generates predictive risk alerts, and offers a 360-degree patient view to support multidisciplinary teams. This capability helps hospitals anticipate clinical deterioration, optimize treatment duration, and improve overall operational efficiency.

Leia offers an AI‑powered mobile app that consolidates a pet’s medical records—including vaccines, prescriptions, and symptoms—into a searchable dossier, automatically extracting data from photos, audio notes, and documents. The app provides smart reminders for care tasks, activity‑linked weight monitoring, and AI‑driven health insights, with optional virtual veterinary consultations via a freemium subscription model.

VivaWell provides a digital health and wellness platform that uses AI and data science to deliver personalized health programs and quality healthcare. It helps individuals and organizations improve health outcomes and manage healthcare costs through tailored services and population health insights.

Salva Health develops a portable screening device that utilizes artificial intelligence to detect breast abnormalities, providing women in remote areas with access to early cancer detection. This technology addresses the lack of affordable and safe screening options, aiming to reduce breast cancer mortality rates globally.

DoctorAssistant.ai provides an AI-powered platform that records medical consultations in real time, transcribes the dialogue, and generates structured clinical notes with suggested ICD codes and parsed exam results. The web‑based solution offers customizable SOAP or specialty templates, secure end‑to‑end encryption, and integration with major EHR systems to streamline documentation for physicians and healthcare facilities.

PRORADIS provides integrated health diagnostic solutions, including RIS, PACS, and LIS management, to streamline operations for diagnostic centers and laboratories. Their platform enhances efficiency and diagnostic accuracy through features like a unified telerradiology interface and AI-assisted analysis.

Huna develops an AI engine that analyzes routine blood test data to identify risk patterns for early cancer detection and other chronic diseases. This technology enables healthcare providers to classify patients by risk level, improving clinical decision-making and increasing the chances of successful treatment while reducing overall healthcare costs.

Movva applies behavioral science and Artificial Intelligence to create personalized content strategies for higher education institutions. This platform directly targets student attrition by addressing individual barriers throughout the academic journey. The result is increased student retention, enhanced engagement, and measurable revenue growth for educational providers.

Longevity Medical Institute offers advanced regenerative therapies and integrated diagnostics to improve healthspan and vitality. They provide personalized treatment protocols using stem cell and exosome therapies, alongside AI-enhanced imaging and comprehensive laboratory analysis for age-related and chronic conditions.

Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.

This startup provides an AI-powered sensor data analytics platform that collects and analyzes real-time sensor data from industrial assets. The platform helps businesses improve asset reliability, enhance process safety, and optimize maintenance operations by identifying potential issues and minimizing downtime.

The startup develops an electronic sedation system that monitors vital signs such as heart rate, respiratory rate, and pulse oximetry without requiring sensors on the patient. Its AVD-M monitor utilizes machine vision and artificial intelligence for remote, non-contact patient monitoring, enhancing safety and reducing costs in anesthesia care delivery.

Serena offers an AI-enabled platform that monitors lifestyle factors to identify early signs of chronic diseases, enabling proactive health management for individuals, employers, and healthcare providers. By providing actionable insights, Serena helps reduce healthcare costs and improve overall well-being through targeted interventions in nutrition, physical activity, and mental health.

Arkangel AI is a no-code platform that transforms medical data into AI algorithms for early disease detection, enabling healthcare organizations to build and deploy tailored solutions efficiently. By streamlining processes such as patient triage and drug adverse effect prediction, Arkangel AI enhances healthcare outcomes while significantly reducing operational costs.

The startup has developed a clinical research platform that utilizes machine learning to target the biological processes of aging, facilitating the discovery of therapies for age-related diseases such as cardiovascular and neurodegenerative conditions. By enabling pharmaceutical companies to enhance medical treatments, the platform addresses the need for more effective interventions in aging-related health issues.

Vennx offers integrated Governance, Risk, and Compliance (GRC) solutions powered by AI to help organizations manage complex regulatory environments. Their platform automates GRC functions, provides real-time access monitoring, and delivers AI-driven diagnostics to enhance security, ensure compliance, and mitigate risks.

Vitazi provides Oculomics-as-a-Service by using AI analytics on retinal scans to detect systemic health risks like diabetes and cardiovascular disease. The platform integrates seamlessly into existing clinical workflows, offering multi-disease detection beyond standard eye disease screening. This enables earlier intervention and supports value-based care metrics for eye care professionals.

Xtrava develops a versatile lateral flow reader that integrates with a cloud platform and mobile app for real-time tracking and analysis of pandemic spread. Their technology provides accurate at-home testing with enhanced sensitivity, ensuring reliable results while simplifying the testing process for users, including those with accessibility needs.

Blue AI is a no-code AI platform that utilizes machine learning models, primarily XGBoost and natural language processing, to analyze health claims data for employers and healthcare providers in Latin America. It identifies potential fraud, unnecessary procedures, and predicts avoidable hospitalizations, enabling businesses to proactively manage healthcare costs and improve patient care efficiency.

Vlab provides a digital platform for the collection, organization, and exploration of medical video data, including ultrasound and endoscopy recordings. This technology replaces outdated storage methods, enabling healthcare providers to enhance patient experiences, improve diagnostic accuracy, and facilitate medical education through structured datasets.

The startup operates a genomics platform that centralizes and integrates DNA data to provide precise diagnoses and personalized treatment plans through advanced data analysis and interpretation. By leveraging genomic information, the platform enables researchers to enhance health outcomes and preventive care strategies for individuals.

The startup provides a regulatory compliance automation platform that employs machine learning algorithms to monitor and analyze regulatory changes in real-time across multiple industries. This solution minimizes the risk of non-compliance and significantly reduces the manual effort required for businesses to stay informed about evolving regulations.

Kintsu is a healthtech platform connecting patients, healthcare professionals, and institutions to improve care coordination. The platform facilitates communication and data sharing to streamline healthcare delivery and enhance patient outcomes.

The startup has developed a molecular diagnostic platform that integrates advanced fluidics, engineering, and bioinformatics to create a user-friendly in vitro diagnostic system. This technology enables healthcare providers to deliver precise clinical genomic information to patients, enhancing accessibility to essential diagnostics for improved treatment outcomes.

Scout provides molecular diagnostic testing that achieves 99% agreement with high-complexity PCR results in 30 minutes. This patented technology eliminates the trade-off between accuracy, speed, and cost often seen in traditional diagnostics. The ultra-portable system enables decisive, near-patient diagnosis and treatment in various care settings.

NeuroGeneces offers the NeuroInsight™ assessment, which utilizes biometric sensors and AI algorithms to detect atypical brain decline up to two decades before symptoms appear, enabling timely intervention. Additionally, the NeuroGevity system enhances memory consolidation by stimulating slow-wave sleep through synchronized sound, improving brain activity related to memory preservation.

Diag-Nose.io develops the RhinoMAP platform to decode airway biology for respiratory diseases. This platform integrates nasal microsampling, proteomics, and machine learning algorithms to analyze biomarker data. The goal is to enable precision medicine by identifying root causes, leading to faster, more effective treatment selection for patients.

Viziomed provides artificial intelligence solutions for medical imaging diagnostics, including radiography and mammography, utilizing advanced algorithms to enhance accuracy and efficiency. The platform reduces diagnostic errors by up to 15% and increases report generation speed by 40%, ultimately improving patient care through earlier detection of conditions.